In vivo imaging of the tumor and its associated microenvironment using combined CARS / two-photon microscopy by Lee, Martin et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In vivo imaging of the tumor and its associated
microenvironment using combined CARS / two-photon
microscopy
Citation for published version:
Lee, M, Downes, A, Chau, Y, Serrels, B, Hastie, N, Elfick, A, Brunton, V, Frame, M & Serrels, A 2015, 'In
vivo imaging of the tumor and its associated microenvironment using combined CARS / two-photon
microscopy' IntraVital, pp. 00-00. DOI: 10.1080/21659087.2015.1055430
Digital Object Identifier (DOI):
10.1080/21659087.2015.1055430
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
IntraVital
Publisher Rights Statement:
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The moral rights of the named author(s) have been
asserted.
Permission is granted subject to the terms of the License under which the work was published. Please check the
License conditions for the work which you wish to reuse. Full and appropriate attribution must be given. This
permission does not cover any third party copyrighted material which may appear in the work requested.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
This article was downloaded by: [The University of Edinburgh]
On: 17 July 2015, At: 01:56
Publisher: Taylor & Francis
Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: 5 Howick Place,
London, SW1P 1WG
Click for updates
IntraVital
Publication details, including instructions for authors and subscription information:
http://www.tandfonline.com/loi/kinv20
In vivo imaging of the tumor and its associated
microenvironment using combined CARS / 2-photon
microscopy
Martin Leea, Andy Downesb, You-Ying Chauc, Bryan Serrelsa, Nick Hastiec, Alistair Elfickb,
Valerie Bruntona, Margaret Framea & Alan Serrelsa
a Edinburgh Cancer Research Center; Institute of Genetics and Molecular Medicine;
University of Edinburgh; Edinburgh, United Kingdom
b School of Engineering; University of Edinburgh; Edinburgh, United Kingdom
c Medical Research Council Human Genetics Unit; Institute of Genetics and Molecular
Medicine; University of Edinburgh; Edinburgh, United Kingdom
Accepted author version posted online: 08 Jun 2015.
To cite this article: Martin Lee, Andy Downes, You-Ying Chau, Bryan Serrels, Nick Hastie, Alistair Elfick, Valerie Brunton,
Margaret Frame & Alan Serrels (2015) In vivo imaging of the tumor and its associated microenvironment using combined
CARS / 2-photon microscopy, IntraVital, 4:1, e1055430, DOI: 10.1080/21659087.2015.1055430
To link to this article:  http://dx.doi.org/10.1080/21659087.2015.1055430
PLEASE SCROLL DOWN FOR ARTICLE
Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained in
the publications on our platform. Taylor & Francis, our agents, and our licensors make no representations or
warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Versions
of published Taylor & Francis and Routledge Open articles and Taylor & Francis and Routledge Open Select
articles posted to institutional or subject repositories or any other third-party website are without warranty
from Taylor & Francis of any kind, either expressed or implied, including, but not limited to, warranties of
merchantability, fitness for a particular purpose, or non-infringement. Any opinions and views expressed in this
article are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The
accuracy of the Content should not be relied upon and should be independently verified with primary sources
of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands,
costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in
connection with, in relation to or arising out of the use of the Content.
 
This article may be used for research, teaching, and private study purposes. Terms & Conditions of access and
use can be found at http://www.tandfonline.com/page/terms-and-conditions
 
It is essential that you check the license status of any given Open and Open Select article to confirm
conditions of access and use.
In vivo imaging of the tumor and its associated
microenvironment using combined
CARS / 2-photon microscopy
Martin Lee1, Andy Downes2, You-Ying Chau3, Bryan Serrels1, Nick Hastie3, Alistair Elﬁck2, Valerie Brunton1, Margaret Frame1,
and Alan Serrels1,*
1Edinburgh Cancer Research Center; Institute of Genetics and Molecular Medicine; University of Edinburgh; Edinburgh, United Kingdom; 2School of Engineering; University
of Edinburgh; Edinburgh, United Kingdom; 3Medical Research Council Human Genetics Unit; Institute of Genetics and Molecular Medicine; University of Edinburgh; Edinburgh,
United Kingdom
Keywords: CARS, Cancer, Coherent Raman microscopy, Harmonic generation, Invasion, Intra-vital microscopy, Multi-photon,
Optical Window, Squamous Cell Carcinoma, SHG, Tumor microenvironment
The use of confocal and multi-photon microscopy for intra-vital cancer imaging has impacted on our understanding
of cancer cell behavior and interaction with the surrounding tumor microenvironment in vivo. However, many studies
to-date rely on the use ﬂuorescent dyes or genetically encoded probes that enable visualization of a structure or cell
population of interest, but do not illuminate the complexity of the surrounding tumor microenvironment. Here, we
show that multi-modal microscopy combining 2-photon ﬂuorescence with CARS can begin to address this deﬁcit,
enabling detailed imaging of the tumor niche without the need for additional labeling. This can be performed on live
tumor-bearing animals through optical observation windows, permitting real-time and longitudinal imaging of
dynamic processes within the tumor niche.
Introduction
The dependency on complex tumor / host interactions for
cancer progression has driven the need to exploit advanced imag-
ing technologies such as confocal and multi-photon laser scan-
ning microscopy (MPM) to image deep in tumor tissue in living
animals. The increasing spatial and temporal resolution of these
microscopy techniques, together with the improved imaging
depth offered by multi-photon excitation, has led to studies of
exquisite detail at both the cellular1-5 and subcellular level,
including the application of advanced imaging techniques such
as Fluorescence Recovery After Photo-bleaching (FRAP),6,3
Photo-activation, 6 Photo-switching, 3 and Fluorescence Lifetime
Imaging (FLIM)7-10 within the complex in vivo environment.
However, to-date the most commonly used techniques require
the expression of a fluorescent marker in order to generate suffi-
cient image contrast. Such markers are usually highly specific and
only enable visualization of a single population of cells or a single
type of tissue structure e.g. blood vessels, and thus provide lim-
ited contextual information.
Increasingly 2-photon fluorescence (2-PEF) is being com-
bined with ‘label-free’ non-linear optical methodologies, includ-
ing Second and Third Harmonic Generation (SHG and THG,
respectively) for intra-vital cancer imaging. This enables visualiza-
tion of a range of structures deep within tumor tissue, including
fibrillar collagen,1,11 nerves, muscle, adipose cells, and blood ves-
sels,2,12 providing greater detail within the image without the need
for further addition of exogenous labels. While SHG is relatively
specific for imaging collagen and striated myofibers, THG has
offered a more comprehensive view of surrounding tissue struc-
tures, although there remains some issues with the use of high
powered femtosecond pulses which may cause damage, particularly
when continuously imaging in the same plane. 2,13 None-the-less,
this move toward a combinatorial approach of ‘label-dependent’
and ‘label-free’ imaging is attractive as it provides specificity
together with a more general overview of tissue architecture.
Since its resurrection in 1999 by the Xie group at Harvard,
Coherent Anti-Stokes Raman Scattering microscopy (CARS) has
emerged as a promising ‘label-free’ imaging modality that can be
applied to biomedical samples. CARS is a form of fast-acquisi-
tion Raman microscopy that generates image contrast using the
Raman active vibrational frequency of given chemical bonds, and
can be tuned over the Raman spectrum to generate image con-
trast from a wide variety of chemical bonds present within bio-
logical samples. The CARS process is described in more detail
elsewhere.14,15 In the cancer setting, CARS has been used to
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identify changes in lipids within the tumor microenvironment
that occur when on a high-fat diet,16 and to differentiate between
normal and malignant brain tissue.17 Furthermore, the few live
animal studies performed to-date have focused on imaging lipids
in the skin, 18 small intestine,19 and circulating cancer cells,20
and to assess animal myelin histomorphometry.21 Thus, further
investigation is still required to fully exploit the potential of
CARS as an intra-vital imaging tool, both alone and in combina-
tion with other imaging techniques. Here, using a custom-
designed multi-modal CARS imaging system, we have investi-
gated the utility of CARS as a pre-clinical cancer-imaging micro-
scopic tool. When combined with 2-PEF and SHG, we show
that CARS permits direct visualization of the complex tumor
microenvironment and the interaction between tumor and host,
without the addition of label, and at laser powers that maintain
good sample viability.
Results
Chemically selective imaging
Acquisition of spectral information using vibrational imaging
techniques including CARS, stimulated Raman scattering (SRS),
and nonlinear interferometric vibrational imaging (NIVI), has
been reported to enable identification of cells with different mor-
phological features 18,22 and to aid discrimination between nor-
mal and malignant tissue. 22–24 Using a custom designed
2-photon / CARS microscope we examined tumor bearing
Figure 1. Chemically selective imaging of tumor histopathology in MMTV-PyMT mammary tumors. (a) Schematic of the custom designed microscope
used throughout the study – see methods section for further details. Images acquired of tumor bearing mammary fat pads from the MMTV-PyMT mouse
at (b) 2,845 cm¡1, (d) 2,930 cm¡1 and (f) 3,030 cm¡1 highlighting tissue features visible at different CARS frequencies. Each image contains contributions
from OH, CH3 and CH2 stretches in different proportions. To highlight the tissue features corresponding to the 3 chemical stretches (termed OH – water,
CH3 – nucleus and CH2 – cell cytoplasm and lipid droplets) the images were subtracted from one another then manually thresholded. The OH stretch
image (g) was created from 3,030 cm¡1 – 2,930 cm¡1 images, the CH2 stretch image (c) was from 2,845 cm¡1 – 3,030 cm¡1 images, while the CH3
stretch image (e) is created from subtracting the generated OH and CH2 images from the 2,930cm
¡1 image. (h) Combined false color image appears as a
pseudo H & E stain, highlighting nuclei (CH3) in green, cytoplasm (CH2) in red and water (OH) in cyan.
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mammary fat pads immediately following surgically removal
from MMTV-PyMT mice 25 and acquired images at 3 different
CARS frequencies; 2,845 cm¡1 which has been associated with
the lipid asymmetric CH2 stretch, 2,930 cm
¡1 which has been
associated with the protein rich CH3 stretch,
17 and 3,030 cm¡1
which has been associated with the water OH stretch. 22,26
Images acquired at 2,845cm¡1 (Fig. 1b) showed strong contrast
from lipids and the cytoplasmic component of cells, with nuclei
yielding a weaker signal. The area between cell clusters exhibited
little contrast. In comparison, images acquired at 2,930cm¡1
(Fig. 1d) showed good lipid and cytoplasmic contrast, but also
exhibited a prominent nuclear signal. Images acquired at
3,030 cm¡1 (Fig. 1f) appeared as a negative of that acquired at
2,845 cm¡1, highlighting the interstitial fluid filled space sur-
rounding the clusters of tumor tissue. Processing of this spectral
image series using image-based subtrac-
tion and thresholding (described in
detail in Methods) resulted in a com-
bined image akin to a pseudo H & E
stain (Fig 1h), highlighting nuclei, cell
bodies, and tissue architecture, similar
to that reported previously using SRS.
24 Thus, chemically selective imaging
using CARS may enable label-free histo-
pathology of cancerous tissue, and could
provide a rapid intraoperative assess-
ment of breast pathologies in a similar
manner to that proposed using a combi-
nation of non-linear microscopy and a
fluorescent nuclear stain. 27 Further-
more, such an approach should facilitate
label-free longitudinal imaging of tumor
development in mouse models of can-
cer, especially when combined with the
use of optical imaging windows.
Imaging cancer in vivo and the
tumor microenvironment using
multi-modal imaging
To date most cancer-based CARS
microscopy studies have focused on its
potential as a diagnostic tool (as
described above), with the aim of label-
free identification of tumor tissue and
malignant cancer cells. 23,24,28 However,
very little has been done to investigate
the potential utility of CARS to image
the cancer cells and the relationship of
these to their immediate environment.
We therefore examined tumor tissue fol-
lowing surgical resection from the mouse
by combining CARS, 2-PEF and SHG.
Using tumors established from a GFP-
expressing mouse Squamous Carcinoma
Cell line (SCC), we simultaneously
acquired CARS images at 2,930 cm¡1,
together with 2-photon excited GFP fluorescence and SHG aris-
ing from the collagen matrix (Fig. 2 and Supplementary Movie
1). The images highlighted a number of interesting features that
could be discerned by the co-generation of a CARS image. Firstly,
Red Blood Cells (RBC) within tumor infiltrating blood vessels
and the endothelial cells layering the wall of the vasculature were
readily visualized (Fig. 2 top right panel, outlined with dashed
white line). Moreover, we could identify individual endothelial
cell bodies lining the vasculature (Fig. 2 top right panel, asterisk),
enabling us to establish that endothelial cells were present and
that the endothelial wall of the vasculature was intact. Secondly,
cancer cells can be seen pushing out small protrusions, potentially
what others have called invadopodia or filopodia, through the
perivascular collagen to contact endothelial cells in what could
represent the early stages of intravasation (Fig. 2 bottom left
Figure 2.Multi-modal imaging of cancer. Top Left – Representative image from a z-stack taken 35 mm
below the tumor surface showing GFP-labeled SCC cancer cells (Green), collagen matrix imaged using
SHG (red), and a range of cell types including red blood cells (RBC), endothelial cells, and tumor inﬁl-
trating immune and stromal cells imaged using CARS (Cyan). Top right - Small region from the left
image showing RBCs, endothelial cells lining a blood vessel (each cell body is marked with *) and inﬁl-
trating host cells (solid arrow). Bottom left –Small region from the top left image showing a tumor cell
pushing out invadopodia or ﬁllopodia (dashed arrow) through the perivascular collagen toward the
endothelial lining (dashed line) of the adjacent blood vessel. This cell appears to be in contact with
host cells (solid arrow). Bottom right – Small region from the top left image showing a group of cancer
cells (solid arrow) that have invaded through the perivascular collagen (boundary delineated with
dashed line) and are pushing on the endothelial cell wall of a blood vessel.
www.tandfonline.com e1055430-3IntraVital
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panel, broken arrows). Interestingly, the CARS image also showed
that these cells are in contact with a host cell, which would sup-
port the role of tumor/host interaction during intravasation (solid
arrow). Thirdly, using SHG we observed groups of cancer cells
invading through the perivascular collagen, and pushing on the
endothelial cell wall creating an invagination into the blood vessel
(Fig. 2 bottom right panel, solid arrow). This may represent fur-
ther stages of intravasation post-degradation of perivascular colla-
gen, but prior to breaching of the endothelial lining of the blood
vessel. As shown here, the combination of CARS, 2-PEF, and
SHG can provide excellent resolution of the relationship between
tumor cells and features of their environment, and this may help
to define the process of intravasation over time.
Cancer cells are thought to use a variety of structures as tracks
along which to invade, including collagen fibers, adipose cells,
nerves, blood vessels, and muscle fibers.2,12 Using THG, Friedl
and colleagues were able to visualize these components of the
microenvironment.2 We therefore addressed whether CARS could
also enable imaging of such structures, but providing the advan-
tage of using lower laser powers that do not cause visible photo-
damage when continuously scanned (Fig. S1 and Supplementary
Movie 7). Using GFP-labeled SCC tumors immediately following
surgical resection from the mouse, we acquired CARS, 2-PEF,
and SHG images from a variety of regions at the tumor margins
(Fig. 3a). Using SHG we were able to visualize cancer cells aligned
along the collagen matrix (Fig. 3a image 1), and invading along
the perivascular collagen of a large blood vessel that was identified
by CARS (Fig. 3a image 2, solid arrow). In addition, using CARS
we could also see cancer cells interacting with adipose cells and
local sites of invasion around clusters of adipose cells (Fig. 3a
image 3, solid arrow), muscle fibers (Fig. 3a image 4, solid
arrows), nerve cells (Fig. 3a image 5, solid arrows), and microvas-
cular structures within the skin (Fig. 3a image 6, solid arrows).
It has also previously been reported that host cells, such as
macrophages and stromal fibroblasts, can assist tumor cell inva-
sion and intravasation by a variety of mechanisms.4,5,29 Using
multi-site image acquisition of a 5 £ 5 grid and subsequent image
tiling, we reconstructed a GFP-labeled SCC tumor within the
skin and identified a tumor edge with cells invading out into the
surrounding collagen (Fig. 3b, left panel, Supplementary Movie
2). CARS imaging at the invasive edge revealed an area of intense
tumor / host interaction, supporting the recognized role that host
cells play in assisting this process. At this point we do not know
the identity of the host cell/s identified using CARS. It has been
shown that tumor cells are extensively involved in re-modeling
the extracellular matrix.30 We observed marked changes in the
collagen abundance and orientation within the tumor (Fig. 4a)
with collagen appearing as less dense, straighter and more aligned
than those found outside of the tumor boundary. To quantify
this result sequential images were taken at tumor borders
(Fig. 4b) so that the center image contained the border of the
tumor and the collagen content from the adjacent images repre-
sented tumor and outside. The collagen content of the images
were then measured for coherency, which represents the propen-
sity for collagen fibers to be aligned in the same orientation, 31
and abundance. Collagen fibers within the tumor were found to
be significantly less abundant and more orientated (Fig. 4c and d)
than those found outside the tumor suggesting that tumor cells
may be responsible for orientating and degrading collagen fibers.
We next addressed whether CARS could be applied in vivo
using dorsal skinfold optical observation windows, enabling
Figure 3. Multi-modal imaging of cancer invasive tracks. (a) Representa-
tive images showing how a combination of SHG (Red) and CARS (Cyan)
can be used to identify a range of invasive tracks used by cancer cells
(Green). Tumor margin, dashed line; invading cells, solid arrow; BV, blood
vessel; AC, adipose cell; TM, tumor margin; MF, muscle ﬁber; N, nerve. (b)
Representative image showing tumor / host interaction at the invading
margin of a tumor. GFP-labeled SCC cancer cells (Green) are seen invad-
ing out from the tumor margin through the collagen matrix (SHG - Red).
These invading tumor cells are accompanied by an intense host cell
component imaged using CARS tuned to 2,845 cm¡1 (Cyan). The invad-
ing margin is delineated with a gray dashed line and the area magniﬁed
in the right image is marked by a white box on the left image.
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dynamic measurements at moderate laser powers that do not
compromise tissue viability. We found that image quality was
slightly lessened when using windows, although features such as
endothelial cells remained visible (Supplementary Video 4).
Movement of the tissue was kept to a minimum as the window
was clamped in place, but breathing and other mouse movement
can cause flickering artifacts across sections of the image. We
focused on blood flow as an example of a highly dynamic process
occurring within tumors, and asked whether CARS could pro-
vide a quantitative measure of relative blood flow, so permitting
sub-classification of blood vessels. Time-lapse imaging of blood
flow within GFP-labeled SCC tumors established under optical
windows revealed considerable heterogeneity in the rate of blood
flow, with vessels displaying different blood flow speeds branch-
ing from each other (Fig. 5a). Using particle tracking in silico,
we determined the velocity of un-labeled individual RBCs flow-
ing through a variety of vessels (Fig. 5b and Supplementary
Movies 4 - 6), and using image thresholding we calculated the
area occupied by RBCs over the total area of the blood vessel as a
measure of hematocrit (the percentage of RBCs in the blood)
(Fig. 5c). Both RBC velocity and hematocrit have been reported
to affect tissue oxygenation levels, and to affect each other with a
consequent impact on oxygenation32. Thus, it may be possible to
infer the chances of a given tumor region being subject to low
oxygen levels and hence its degree of hypoxia. In this regard, one
could also analyze responses to vascular modifying anti-cancer
agents. It was also notable that RBCs in some vessels were in very
close contact (less than 1 mm) with cancer cells, which may sug-
gest an absence of an endothelial vessel wall (Fig. 5d), although
the visibility of these cells are affected by the contrast of the sur-
rounding tissue, and the faster acquisition times used in live imag-
ing. For blood vessels in which RBC velocity was too fast for
particle tracking, i.e. those in which the blood flow was faster
than the acquisition frame rate, we adopted an alternative method
for image acquisition and analysis originally proposed by Kamoun
et al, termed Relative Velocity Field Scanning (RVFS).33 This
technique is based on the use of slow scanning speeds to create
distorted images of RBCs and the residence time and distance
traveled used to calculate velocity (Fig. 5e). Application of this
approach using CARS images successfully enabled the quantifica-
tion of RBC velocity where single cell RBC tracking was not pos-
sible, and further highlighted the heterogeneity of blood flow rate
within tumor vasculature. Therefore, CARS provides a visualiza-
tion and analysis tool for blood vessels, and enables their sub-cate-
gorization based on flow rate and RBC content without the use
of any label. When combined with 2-PEF this analysis may
Figure 4. Quantifying collagen changes. (a) Representative render showing the collagen present at the border of an SCC tumor (indicated by dashed
line). Z-stack taken between 30 and 67 mm below the tumor capsule. (b) Representative images taken from a 3 image series scanned across the border
of a tumor with the central image aligned perpendicular and central to the tumor border. Collagen coherency and amount was calculated from the left
and right images via the OrientationJ plugin for ImageJ and thresholded area respectively. (c and d) Collagen coherency and abundance (mean § SEM)
in tumor and outside. n D 22, paired t-test.
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facilitate correlation between blood flow parameters and localized
tumor cell characteristics. It represents a viable label-free approach
to complement other techniques that use the standard vascular
contrast agents, such as fluorescently conjugated BSA, dextrans, or
quantum dots. While these label vascular structures, to our knowl-
edge they do not enable direct visualization of blood cells
although it may be possible to infer these findings from the nega-
tive contrast of blood cells against a labeled vascular agent.
Figure 5. Quantifying tumor blood ﬂow. (a) Representative image showing heterogeneity in blood ﬂow rate within tumors. A cancer cell can be seen in
close contact with Red Blood Cells (RBC), area magniﬁed is indicated with dashed box and potentially intravasating cell marked with solid arrow. (b) Rep-
resentative images taken from 3 separate time-lapse series acquired through dorsal skinfold windows showing label-free tracking of RBC ﬂow within
tumor vasculature (multi-colored lines). Lipid rich perivascular host cells (solid arrow), possibly macrophages, are evident. Right – Graph showing quantiﬁ-
cation of 5 slow moving vessels showing heterogeneity of RBC ﬂow rate between different vessels. Only branch n D14; Fast branch, Left branch, Right
branch n D 5; Slow branch n D 3. (c) Hematocrit quantiﬁcation of 5 slow moving vessels. Each image from a 40 image time-series was quantiﬁed and
standard error of the mean calculated. Graph shows median, upper and lower quartile, and minimum / maximum values. (d) Representative image show-
ing RBCs in close contact with tumor cells in what may represent vascular mimicry. Upper panel is magniﬁed area marked by dashed box in lower panel.
(e) Representative images taken from 3 separate time-series’ acquired through dorsal skinfold windows showing label-free quantiﬁcation of fast-ﬂowing
RBCs within tumor associated blood vessels. Bottom – Graph showing quantiﬁcation of RBC velocity within each of the 3 vessels. A minimum of 8 blood
cells were tracked. Right bottom – formula used to calculate RBC velocity (Vrcb), d D distance traveled during scan, t D time, rcbL D average red blood
cell diameter. Image acquisition for all images was performed using the CARS stretch at 2,930 cm¡1 (Red) and acquired alongside GFP-labeled SCC can-
cer cells (Green) and SHG (cyan).
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Discussion
We have found that simultaneous acquisition of 2-PEF, SHG,
and CARS imaging modalities can enhance detailed studies
within un-processed tissue ex vivo and in tumor bearing live ani-
mals, and at laser powers that do not cause visible photo-damage.
One strength of CARS as a pre-clinical imaging tool is to enable
detailed description of ‘in tissue’ environments over time, and
the relationship between cancer cells and their niche, particularly
when used in combination with 2-PEF and SHG. Together these
can provide exquisite detail of tissue structures, blood flow, vas-
cular integrity, tumor / host interaction, and tumor associated
processes that are visibly linked to invasion and intravasation.
Third Harmonic Generation is a valuable technique to iden-
tify tissue structures in tumor environments, and has been instru-
mental in identifying that cancer cells exploit a variety of
structures such as adipose cells, nerves, and muscle as tracks along
which to invade and migrate2. However, there are some issues
with timelapse and continuously imaging the same area of tissue
with Drosophila embryo survival dropping when the illumination
time was above 20% of the total imaging time and blood flow
monitored in mouse dorsal skin fold chambers ceasing after 60
seconds of continuous imaging.2,13 Here, we have shown that
CARS, using a picosecond pulsed laser source, can permit imag-
ing of a similar variety of structures within tissue (Fig. 3). CARS
is also able to continuously image the same region without visible
photodamage to track dynamic changes. Indeed, 300 frames of
continuous imaging did not show any signs of visible photo-dam-
age, suggesting that the image acquisition parameters being
applied are conducive to long-term imaging deep within tissue
(Fig. S1 and Supplementary Movie 7). These benefits are further
enhanced by the added flexibility of being tunable to produce
images from across the Raman spectrum, yielding detailed mor-
phological and structural information similar to that attained
from haematoxylin and eosin staining routinely used in histologi-
cal examination of fixed tissue. We conclude that multi-modal
CARS / 2-photon imaging represents a very promising method
for imaging structure / function relationships within cancer tis-
sues and at exposure to modest laser power.
The application of multi-modal CARS imaging to the real-
time study of cancer in vivo has the potential to impact in a num-
ber of important areas that remain poorly understood. Using this
approach we have observed cancer cells projecting structures, akin
to what others have termed invadopodia or filopodia, through the
perivascular collagen network to contact the endothelial cells lin-
ing the vasculature. These invasion-associated structures are
known to be rich in matrix metalloproteinase activity, and drive
local degradation of the extracellular matrix (ECM).34 Interaction
with tumor infiltrating host cells may play an important role in
promoting this behavior, and multi-modal imaging enables the
real-time visualization of such complex 4-way interactions
between cancer cells, the ECM, endothelial cells, and tumor infil-
trating host immune cells. Thus the temporal kinetics of such
complex interactions could be monitored and help inform on the
dynamic nature of tumor / host interactions that underpin pro-
cesses including intravasation and extravasation.
Tumor vasculature plays a vital role in not only sustaining
tumor growth, but also in enabling tumor cell dissemination and
ultimately metastasis. Properties including blood flow rate and
hematocrit will likely have effects on local tumor cell behavior,
through for example influencing local oxygenation or through
increased shear forces affecting survival of intravasating cancer
cells. Imaging these properties in conjunction with local tumor
cell behavior may help us understand the influence of blood flow
characteristics and their local impact on cancer cells and even
activity of cancer driver pathways. Indeed, measurements of can-
cer driver pathway activation, such as Src,8 RhoA 9 and Rac,7
have recently been reported using in vivo FLIM imaging of
FRET (Fluorescence Resonance Energy Transfer) biosensors,
and others have shown that multi-modal CARS 2-photon imag-
ing can be combined with FLIM.35 Therefore interrogation of
the relationship between blood flow characteristics and intracellu-
lar signaling in cancer cells may be realistically achievable using a
combination of these technologies integrated onto a single imag-
ing system. In addition to quantification of RBC velocity and
number, CARS also facilitates visualization of endothelial cells
lining the blood vessels and visual inspection of the integrity of
the endothelial lining of the blood vessel. In combination with 2-
photon fluorescence to image fluorescently labeled cancer cells,
this could represent a valuable approach for real-time identifica-
tion of ruptured vascular walls during the process of intravasa-
tion, or even the identification of vascular mimicry.
In summary, here we provide evidence that CARS has enor-
mous potential when combined with 2-photon microscopy in
imaging the internal environment in tissue and tumors, including
in living animals. In the future, an exciting possibility is that the
successes of Raman based techniques in identifying immune cell
types,36,37 differences between normal, benign and malignant tis-
sues,38-40 and the discrimination between drug sensitive and
drug resistant tumors,41 may be transferable to coherent Raman
imaging by further developing and exploiting the spectroscopic
data generated while imaging.
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